{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:35:25Z","timestamp":1792096525726,"version":"4.4.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ccm.2022.07.002","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T19:45:06Z","timestamp":1667591106000},"page":"821-840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Update on Lung Transplantation for Cystic Fibrosis"],"prefix":"10.1016","volume":"43","author":[{"given":"Joseph M.","family":"Pilewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ccm.2022.07.002_bib1","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.healun.2021.07.021","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult lung transplantation report - 2021; Focus on recipient characteristics","volume":"40","author":"Chambers","year":"2021","journal-title":"J\u00a0Heart Lung Transpl"},{"key":"10.1016\/j.ccm.2022.07.002_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/M13-0636","article-title":"Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry","volume":"161","author":"MacKenzie","year":"2014","journal-title":"Ann Intern Med"},{"issue":"Suppl 2","key":"10.1016\/j.ccm.2022.07.002_bib3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/ajt.15279","article-title":"OPTN\/SRTR 2017 annual data report: lung","volume":"19","author":"Valapour","year":"2019","journal-title":"Am J Transpl"},{"key":"10.1016\/j.ccm.2022.07.002_bib4","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJM199204303261804","article-title":"Prediction of mortality in patients with cystic fibrosis","volume":"326","author":"Kerem","year":"1992","journal-title":"New Engl J Med"},{"issue":"6","key":"10.1016\/j.ccm.2022.07.002_bib5","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.chest.2017.01.019","article-title":"Heterogeneity in survival in adult patients with cystic fibrosis with FEV1 < 30% of predicted in the United States","volume":"151","author":"Ramos","year":"2017","journal-title":"Chest"},{"issue":"19","key":"10.1016\/j.ccm.2022.07.002_bib6","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"VX17-445-102 Study Group. Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.ccm.2022.07.002_bib7","first-page":"32597","article-title":"VX17-445-103 Trial Group. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"S0140-6736","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2022.07.002_bib8","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1164\/rccm.200202-087OC","article-title":"Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality","volume":"166","author":"Mayer-Hamblett","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2022.07.002_bib9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1034\/j.1399-3046.2001.00019.x","article-title":"Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients","volume":"5","author":"Augarten","year":"2001","journal-title":"Pediatr Transplant"},{"issue":"1","key":"10.1016\/j.ccm.2022.07.002_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12890-017-0367-9","article-title":"Cystic fibrosis physicians' perspectives on the timing of referral for lung transplant evaluation: a survey of physicians in the United States","volume":"17","author":"Ramos","year":"2017","journal-title":"BMC Pulm Med"},{"issue":"3","key":"10.1016\/j.ccm.2022.07.002_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcf.2019.03.002","article-title":"CF lung transplant referral guidelines committee. Lung transplant referral for individuals with cystic fibrosis: cystic fibrosis foundation consensus guidelines","volume":"18","author":"Ramos","year":"2019","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.ccm.2022.07.002_bib12","doi-asserted-by":"crossref","unstructured":"Perez AA, Singer JP, Schwartz BS, et\u00a0al. Management and clinical outcomes after lung transplantation in patients with pre-transplant Mycobacterium abscessus infection: a single center experience. Transpl Infect Dis. 2019;21(3):e13084","DOI":"10.1111\/tid.13084"},{"key":"10.1016\/j.ccm.2022.07.002_bib13","doi-asserted-by":"crossref","unstructured":"Raats D, Lorent N, Saegeman V, et\u00a0al. Successful lung transplantation for chronic Mycobacterium abscessus infection in advanced cystic fibrosis, a case series. Transpl Infect Dis. 2019;21(2):e13046.","DOI":"10.1111\/tid.13046"},{"key":"10.1016\/j.ccm.2022.07.002_bib14","doi-asserted-by":"crossref","unstructured":"Hamad Y, Pilewski JM, Morrell M, et\u00a0al. Outcomes in lung transplant recipients with Mycobacterium abscessus infection: a 15-year experience from a large Tertiary care center. Transpl Proc. 2019;51(6):2035-2042.","DOI":"10.1016\/j.transproceed.2019.02.028"},{"key":"10.1016\/j.ccm.2022.07.002_bib15","doi-asserted-by":"crossref","unstructured":"Dedrick RM, Guerrero-Bustamante CA, Garlena RA, et\u00a0al. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat Med. 2019;25(5):730-733.","DOI":"10.1038\/s41591-019-0437-z"},{"key":"10.1016\/j.ccm.2022.07.002_bib16","doi-asserted-by":"crossref","unstructured":"Nash KL, Allison ME, McKeon D, et\u00a0al. A single centre experience of liver disease in adults with cystic fibrosis 1995-2006. J cystic fibrosis : official J Eur Cystic Fibrosis Soc 2008;7:252-257.","DOI":"10.1016\/j.jcf.2007.10.004"},{"key":"10.1016\/j.ccm.2022.07.002_bib17","doi-asserted-by":"crossref","unstructured":"Rowland M, Gallagher CG, O'Laoide R, et\u00a0al. Outcome in cystic fibrosis liver disease. Am J Gastroenterol 2011;106:104-109.","DOI":"10.1038\/ajg.2010.316"},{"key":"10.1016\/j.ccm.2022.07.002_bib18","doi-asserted-by":"crossref","unstructured":"Nash EF, Volling C, Gutierrez CA, et\u00a0al. Outcomes of patients with cystic fibrosis undergoing lung transplantation with and without cystic fibrosis-associated liver cirrhosis. Clin Transplant 2012;26:34-41.","DOI":"10.1111\/j.1399-0012.2010.01395.x"},{"key":"10.1016\/j.ccm.2022.07.002_bib19","doi-asserted-by":"crossref","unstructured":"Salman J, Grannas G, Ius F, et\u00a0al. The liver-first approach for combined lung and liver transplantation. Eur J Cardiothorac Surg. 2018;54(6):1122-1127","DOI":"10.1093\/ejcts\/ezy217"},{"key":"10.1016\/j.ccm.2022.07.002_bib20","doi-asserted-by":"crossref","unstructured":"Lederer DJ, Wilt JS, D'Ovidio F, et\u00a0al. Obesity and underweight are associated with an increased risk of death after lung transplantation. Am J Respir Crit Care Med 2009;180:887-895.","DOI":"10.1164\/rccm.200903-0425OC"},{"key":"10.1016\/j.ccm.2022.07.002_bib21","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.chest.2019.11.043","article-title":"Underweight patients with cystic fibrosis are suitable candidates for lung transplantation","volume":"157","author":"Ramos","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2022.07.002_bib22","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.healun.2012.02.012","article-title":"Low vitamin D levels are associated with increased rejection and infections after lung transplantation","volume":"31","author":"Lowery","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ccm.2022.07.002_bib23","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.healun.2021.07.005","article-title":"Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation","volume":"40","author":"Leard","year":"2021","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.ccm.2022.07.002_bib24","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0022-5223(98)70285-5","article-title":"Pediatric and adult lung transplantation for cystic fibrosis","volume":"115","author":"Mendeloff","year":"1998","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ccm.2022.07.002_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0003-4975(92)91135-V","article-title":"Double-lung transplantation for cystic fibrosis. The cystic fibrosis transplant study group","volume":"54","author":"Shennib","year":"1992","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ccm.2022.07.002_bib26","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1016\/j.transproceed.2005.06.038","article-title":"Evolving techniques and perspectives in lung transplantation","volume":"37","author":"Venuta","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ccm.2022.07.002_bib27","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0022-5223(99)70434-4","article-title":"Bilateral sequential lung transplantation without sternal division eliminates posttransplantation sternal complications","volume":"117","author":"Meyers","year":"1999","journal-title":"The J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ccm.2022.07.002_bib28","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/0003-4975(94)90095-7","article-title":"Living-related donor lobectomy for bilateral lobar transplantation in patients with cystic fibrosis","volume":"57","author":"Cohen","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ccm.2022.07.002_bib29","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/ejcts\/ezu350","article-title":"Living-donor lobar lung transplantation provides similar survival to cadaveric lung transplantation even for very ill patients","volume":"47","author":"Date","year":"2015","journal-title":"Eur J cardio-thoracic Surg : official J Eur Assoc Cardio-thoracic Surg"},{"key":"10.1016\/j.ccm.2022.07.002_bib30","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1067\/mtc.2000.110685","article-title":"Perioperative complications after living donor lobectomy","volume":"120","author":"Battafarano","year":"2000","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ccm.2022.07.002_bib31","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1378\/chest.128.2.720","article-title":"Pneumothorax in cystic fibrosis","volume":"128","author":"Flume","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2022.07.002_bib32","doi-asserted-by":"crossref","unstructured":"Meachery G, De Soyza A, Nicholson A, et\u00a0al. Outcomes of lung transplantation for cystic fibrosis in a large UK cohort. Thorax 2008;63:725-731.","DOI":"10.1136\/thx.2007.092056"},{"key":"10.1016\/j.ccm.2022.07.002_bib33","doi-asserted-by":"crossref","unstructured":"Hadjiliadis D, Steele MP, Chaparro C, et\u00a0al. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria. J Heart Lung Transplant : official Publ Int Soc Heart Transplant 2007;26:834-838.","DOI":"10.1016\/j.healun.2007.05.018"},{"issue":"5","key":"10.1016\/j.ccm.2022.07.002_bib34","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.healun.2019.01.1306","article-title":"Outcomes in cystic fibrosis lung transplant recipients infected with organisms labeled as pan-resistant: an ISHLT Registry\u2012based analysis","volume":"38","author":"Lay","year":"2019","journal-title":"J\u00a0Heart Lung Transpl"},{"key":"10.1016\/j.ccm.2022.07.002_bib35","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1164\/ajrccm.155.5.9154879","article-title":"The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome","volume":"155","author":"Aris","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2022.07.002_bib36","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1164\/rccm.200712-1834OC","article-title":"Impact of burkholderia infection on lung transplantation in cystic fibrosis","volume":"178","author":"Murray","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ccm.2022.07.002_bib37","doi-asserted-by":"crossref","first-page":"e13236","DOI":"10.1111\/ctr.13236","article-title":"Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia dolosa (genomovar VI)","volume":"32","author":"Wang","year":"2018","journal-title":"Clin Transpl"},{"key":"10.1016\/j.ccm.2022.07.002_bib38","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1600-6143.2008.02186.x","article-title":"Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex","volume":"8","author":"Alexander","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ccm.2022.07.002_bib39","doi-asserted-by":"crossref","unstructured":"Boussaud V, Guillemain R, Grenet D, et\u00a0al. Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres. Thorax 2008;63:732-737.","DOI":"10.1136\/thx.2007.089458"},{"issue":"3","key":"10.1016\/j.ccm.2022.07.002_bib40","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jcf.2018.10.013","article-title":"Pre-transplant factors associated with mortality after lung transplantation in cystic fibrosis: a systematic review and meta-analysis","volume":"18","author":"Koutsokera","year":"2019","journal-title":"J\u00a0Cyst Fibros"},{"issue":"9","key":"10.1016\/j.ccm.2022.07.002_bib41","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.healun.2015.05.003","article-title":"Clinical and demographic factors associated with post-lung transplantation survival in individuals with cystic fibrosis","volume":"34","author":"Stephenson","year":"2015","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"10","key":"10.1016\/j.ccm.2022.07.002_bib42","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1097\/TP.0000000000000709","article-title":"Pan-resistant achromobacter xylosoxidans and Stenotrophomonas maltophilia infection in cystic fibrosis does not reduce survival after lung transplantation","volume":"99","author":"Lobo","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.ccm.2022.07.002_bib43","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1001\/jama.2010.791","article-title":"Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis","volume":"303","author":"Dasenbrook","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ccm.2022.07.002_bib44","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/01.TP.0000437434.42851.d4","article-title":"Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis","volume":"97","author":"Luong","year":"2014","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.ccm.2022.07.002_bib45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/tri.12679","article-title":"10 years of prophylaxis with nebulized liposomal amphotericin B and the changing epidemiology of Aspergillus spp. infection in lung transplantation","volume":"29","author":"Peghin","year":"2016","journal-title":"Transpl Int"},{"key":"10.1016\/j.ccm.2022.07.002_bib46","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.healun.2005.12.011","article-title":"Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation","volume":"25","author":"Symoens","year":"2006","journal-title":"J\u00a0Heart Lung Transplant : official Publ Int Soc Heart Transplant"},{"key":"10.1016\/j.ccm.2022.07.002_bib47","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1164\/rccm.200207-678OC","article-title":"Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis","volume":"167","author":"Olivier","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2022.07.002_bib48","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1164\/rccm.200207-679OC","article-title":"Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease","volume":"167","author":"Olivier","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2022.07.002_bib49","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/thx.2005.049247","article-title":"Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation","volume":"61","author":"Chalermskulrat","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2022.07.002_bib50","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/ctr.12140","article-title":"Lung transplant outcomes in cystic fibrosis patients with pre-operative Mycobacterium abscessus respiratory infections","volume":"27","author":"Lobo","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ccm.2022.07.002_bib51","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jcf.2010.03.008","article-title":"Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection","volume":"9","author":"Gilljam","year":"2010","journal-title":"J\u00a0cystic fibrosis"},{"key":"10.1016\/j.ccm.2022.07.002_bib52","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.transproceed.2012.02.035","article-title":"Nontuberculous mycobacterial disease is not a contraindication to lung transplantation in patients with cystic fibrosis: a retrospective analysis in a Danish patient population","volume":"45","author":"Qvist","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ccm.2022.07.002_bib53","first-page":"25","article-title":"Impact of sinus surgery on pseudomonal airway colonization, bronchiolitis obliterans syndrome and survival in cystic fibrosis lung transplant recipients","volume":"86","author":"Vital","year":"2013","journal-title":"Respiration; Int Rev Thorac Dis"},{"key":"10.1016\/j.ccm.2022.07.002_bib54","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1183\/09031936.00128607","article-title":"Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation?","volume":"31","author":"Vos","year":"2008","journal-title":"The Eur Respir J"},{"key":"10.1016\/j.ccm.2022.07.002_bib55","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/TP.0b013e31816651de","article-title":"Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome","volume":"85","author":"Botha","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.ccm.2022.07.002_bib56","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00405-012-2002-y","article-title":"Posttransplant sinus surgery in lung transplant recipients with cystic fibrosis: a single institutional experience","volume":"270","author":"Vital","year":"2013","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.ccm.2022.07.002_bib57","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2500\/ajra.2013.27.3829","article-title":"The effect of sinus surgery with intensive follow-up on pathogenic sinus bacteria in patients with cystic fibrosis","volume":"27","author":"Aanaes","year":"2013","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.ccm.2022.07.002_bib58","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2500\/ajra.2012.26.3705","article-title":"Extensive surgical and comprehensive postoperative medical management for cystic fibrosis chronic rhinosinusitis","volume":"26","author":"Virgin","year":"2012","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.ccm.2022.07.002_bib59","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/lary.24503","article-title":"Medical management of chronic rhinosinusitis in cystic fibrosis: a systematic review","volume":"124","author":"Liang","year":"2014","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ccm.2022.07.002_bib60","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4193\/Rhino15.347","article-title":"Sinus surgery postpones chronic Gram-negative lung infection: cohort study of 106 patients with cystic fibrosis","volume":"54","author":"Alanin","year":"2016","journal-title":"Rhinology"},{"key":"10.1016\/j.ccm.2022.07.002_bib61","doi-asserted-by":"crossref","first-page":"186","DOI":"10.7326\/0003-4819-128-3-199802010-00004","article-title":"Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis","volume":"128","author":"Aris","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccm.2022.07.002_bib62","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1164\/ajrccm.162.3.2002051","article-title":"Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation","volume":"162","author":"Aris","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2022.07.002_bib63","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1164\/rccm.200307-1049OC","article-title":"Efficacy of alendronate in adults with cystic fibrosis with low bone density","volume":"169","author":"Aris","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2022.07.002_bib64","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/dc09-0586","article-title":"Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes care"},{"key":"10.1016\/j.ccm.2022.07.002_bib65","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jcf.2004.08.001","article-title":"Clinical importance of cystic fibrosis-related diabetes","volume":"3","author":"Brennan","year":"2004","journal-title":"J\u00a0cystic fibrosis : official J Eur Cystic Fibrosis Soc"},{"key":"10.1016\/j.ccm.2022.07.002_bib66","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/ajt.12561","article-title":"Diabetes is a major risk factor for mortality after lung transplantation","volume":"14","author":"Hackman","year":"2014","journal-title":"Am J Transplant : official J Am Soc Transplant Am Soc Transpl Surgeons"},{"issue":"5 Pt 2","key":"10.1016\/j.ccm.2022.07.002_bib67","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1600-6143.2006.01276.x","article-title":"Development of the new lung allocation system in the United States","volume":"6","author":"Egan","year":"2006","journal-title":"Am J Transpl"},{"issue":"4","key":"10.1016\/j.ccm.2022.07.002_bib68","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.healun.2016.01.010","article-title":"Effect of the lung allocation score on lung transplantation in the United\u00a0States","volume":"35","author":"Egan","year":"2016","journal-title":"J\u00a0Heart Lung Transpl"},{"key":"10.1016\/j.ccm.2022.07.002_bib69","first-page":"139","article-title":"The lung lawsuit: a case study in organ allocation policy and administrative law","volume":"XIV","author":"Glazier","year":"2018","journal-title":"J\u00a0Health Biomed"},{"key":"10.1016\/j.ccm.2022.07.002_bib70","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.healun.2018.09.007","article-title":"Effect of broader geographic sharing of donor lungs on lung transplant waitlist outcomes","volume":"38","author":"Mooney","year":"2019","journal-title":"J\u00a0Heart Lung Transpl"},{"key":"10.1016\/j.ccm.2022.07.002_bib71","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S1053-2498(02)00667-8","article-title":"Pre-transplant mechanical ventilation and outcome in patients with cystic fibrosis","volume":"22","author":"Bartz","year":"2003","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.ccm.2022.07.002_bib72","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.healun.2009.01.012","article-title":"Lung transplantation for ventilator-dependent respiratory failure","volume":"28","author":"Vermeijden","year":"2009","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.ccm.2022.07.002_bib73","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jcf.2006.12.010","article-title":"Lung transplantation for cystic fibrosis: current concepts and one center's experience","volume":"6","author":"Spahr","year":"2007","journal-title":"J\u00a0cystic fibrosis"},{"key":"10.1016\/j.ccm.2022.07.002_bib74","first-page":"CD002769","article-title":"Non-invasive ventilation for cystic fibrosis","volume":"4","author":"Moran","year":"2013","journal-title":"Cochrane database Syst Rev"},{"key":"10.1016\/j.ccm.2022.07.002_bib75","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.athoracsur.2011.04.122","article-title":"Extracorporeal membrane oxygenation as a bridge to lung transplant: midterm outcomes","volume":"92","author":"Bermudez","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ccm.2022.07.002_bib76","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.jtcvs.2012.12.067","article-title":"Efficacy of extracorporeal membrane oxygenation as a bridge to lung transplantation","volume":"145","author":"Toyoda","year":"2013","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ccm.2022.07.002_bib77","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jcf.2011.07.009","article-title":"Ambulatory venovenous extracorporeal respiratory support as a bridge for cystic fibrosis patients to emergent lung transplantation","volume":"11","author":"Hayes","year":"2012","journal-title":"J\u00a0cystic fibrosis"},{"key":"10.1016\/j.ccm.2022.07.002_bib78","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1164\/rccm.200407-900OC","article-title":"Use of lung transplantation survival models to refine patient selection in cystic fibrosis","volume":"171","author":"Liou","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2022.07.002_bib79","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMoa066359","article-title":"Lung transplantation and survival in children with cystic fibrosis","volume":"357","author":"Liou","year":"2007","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ccm.2022.07.002_bib80","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1399-3046.2008.00924.x","article-title":"Lung transplantation and survival in children with cystic fibrosis: solid statistics--flawed interpretation","volume":"12","author":"Sweet","year":"2008","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.ccm.2022.07.002_bib81","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1164\/rccm.201303-0429OC","article-title":"Survival benefit of lung transplant for cystic fibrosis since lung allocation score implementation","volume":"187","author":"Thabut","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2022.07.002_bib82","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1569-1993(02)00079-6","article-title":"Validation of the SF-36 for the assessment of quality of life in adolescents and adults with cystic fibrosis","volume":"1","author":"Gee","year":"2002","journal-title":"J\u00a0cystic fibrosis"},{"key":"10.1016\/j.ccm.2022.07.002_bib83","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S1569-1993(03)00093-6","article-title":"Quality of life in cystic fibrosis: the impact of gender, general health perceptions and disease severity","volume":"2","author":"Gee","year":"2003","journal-title":"J\u00a0cystic fibrosis"},{"key":"10.1016\/j.ccm.2022.07.002_bib84","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/ppul.20009","article-title":"Improved quality of life after lung transplantation in individuals with cystic fibrosis","volume":"37","author":"Vermeulen","year":"2004","journal-title":"Pediatr pulmonology"},{"key":"10.1016\/j.ccm.2022.07.002_bib85","doi-asserted-by":"crossref","unstructured":"Burker EJ, Carels RA, Thompson LF, et\u00a0al. Quality of life in patients awaiting lung transplant: cystic fibrosis versus other end-stage lung diseases. Pediatr pulmonology 2000;30:453-460.","DOI":"10.1002\/1099-0496(200012)30:6<453::AID-PPUL3>3.3.CO;2-#"},{"key":"10.1016\/j.ccm.2022.07.002_bib86","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jcf.2004.12.005","article-title":"Associations between clinical variables and quality of life in adults with cystic fibrosis","volume":"4","author":"Gee","year":"2005","journal-title":"J\u00a0cystic fibrosis"},{"key":"10.1016\/j.ccm.2022.07.002_bib87","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1164\/rccm.201501-0126OC","article-title":"Effects of recipient age and diagnosis on health-related quality of life benefit of lung transplantation","volume":"192","author":"Singer","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2022.07.002_bib88","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1378\/chest.105.3.911","article-title":"Measuring the quality of life before and after bilateral lung transplantation in patients with cystic fibrosis","volume":"105","author":"Busschbach","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2022.07.002_bib89","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.healun.2017.07.021","article-title":"Report of the ISHLT working group on primary lung graft dysfunction, part I: definition and grading-A 2016 consensus group statement of the international Society for heart and lung transplantation","volume":"36","author":"Snell","year":"2017","journal-title":"J\u00a0Heart Lung Transpl"},{"key":"10.1016\/j.ccm.2022.07.002_bib90","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.healun.2017.07.020","volume":"36","author":"Diamond","year":"2017","journal-title":"J\u00a0Heart Lung Transpl"},{"key":"10.1016\/j.ccm.2022.07.002_bib91","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.healun.2017.07.014","article-title":"Report of the ISHLT working group on primary lung graft dysfunction Part III: mechanisms: A 2016 consensus group statement of the international Society for heart and lung transplantation","volume":"36","author":"Gelman","year":"2017","journal-title":"J\u00a0Heart Lung Transpl"},{"key":"10.1016\/j.ccm.2022.07.002_bib92","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.healun.2017.07.013","article-title":"Report of the ISHLT working group on primary lung graft dysfunction Part IV: prevention and treatment: a 2016 consensus group statement of the international Society for heart and lung transplantation","volume":"36","author":"Van Raemdonck","year":"2017","journal-title":"J\u00a0Heart Lung Transpl"},{"key":"10.1016\/j.ccm.2022.07.002_bib93","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1164\/rccm.201706-1140OC","article-title":"Lung transplant outcomes group. Quantitative evidence for revising the definition of primary graft dysfunction after lung transplant","volume":"197","author":"Cantu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2022.07.002_bib94","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.healun.2018.01.1309","article-title":"ISHLT Consensus Statement on adult and pediatric airway complications after lung transplantation: definitions, grading system, and therapeutics","volume":"37","author":"Crespo","year":"2018","journal-title":"J\u00a0Heart Lung Transpl"},{"key":"10.1016\/j.ccm.2022.07.002_bib95","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.healun.2011.12.009","article-title":"The effect of lung size mismatch on complications and resource utilization after bilateral lung transplantation","volume":"31","author":"Eberlein","year":"2012","journal-title":"J\u00a0Heart Lung Transpl"},{"key":"10.1016\/j.ccm.2022.07.002_bib96","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1164\/rccm.201604-0732OC","article-title":"Parametric response mapping as an imaging biomarker in lung transplant recipients","volume":"195","author":"Belloli","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2022.07.002_bib97","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/ajt.13417","article-title":"Prophylactic azithromycin therapy after lung transplantation: post hoc analysis of a randomized controlled trial","volume":"16","author":"Ruttens","year":"2016","journal-title":"Am J Transpl"},{"key":"10.1016\/j.ccm.2022.07.002_bib98","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.healun.2018.11.014","article-title":"Montelukast in chronic lung allograft dysfunction after lung transplantation","volume":"38","author":"Vos","year":"2019","journal-title":"J\u00a0Heart Lung Transpl"},{"key":"10.1016\/j.ccm.2022.07.002_bib99","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.healun.2018.09.016","article-title":"Bronchiolitis obliterans syndrome-free survival after lung transplantation: an international Society for heart and lung transplantation thoracic transplant registry analysis","volume":"38","author":"Kulkarni","year":"2019","journal-title":"J\u00a0Heart Lung Transpl"},{"key":"10.1016\/j.ccm.2022.07.002_bib100","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.healun.2019.03.008","article-title":"Chronic lung allograft dysfunction: Definition and update of restrictive allograft syndrome-A consensus report from the Pulmonary Council of the ISHLT","volume":"38","author":"Glanville","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ccm.2022.07.002_bib101","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT","volume":"38","author":"Verleden","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ccm.2022.07.002_bib102","article-title":"Effect of including important clinical variables on accuracy of the lung allocation score for cystic fibrosis and chronic obstructive pulmonary disease","volume":"14","author":"Lehr","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2022.07.002_bib103","doi-asserted-by":"crossref","unstructured":"Quon BS, Psoter K, Mayer-Hamblett N, et\u00a0al. Disparities in access to lung transplantation for patients with cystic fibrosis by socioeconomic status. Am J Respir Crit Care Med 2012;186:1008-1013.","DOI":"10.1164\/rccm.201205-0949OC"},{"key":"10.1016\/j.ccm.2022.07.002_bib104","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/ajt.13226","article-title":"National healthcare delivery systems influence lung transplant outcomes for cystic fibrosis","volume":"15","author":"Merlo","year":"2015","journal-title":"Am J Transplant"},{"issue":"18","key":"10.1016\/j.ccm.2022.07.002_bib105","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A\u00a0CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccm.2022.07.002_bib106","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1378\/chest.13-2397","article-title":"Effects of ivacaftor in patients with cystic fibrosis who carry the G551D mutation and have severe lung disease","volume":"146","author":"Barry","year":"2014","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ccm.2022.07.002_bib107","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jcf.2012.12.004","article-title":"The use of ivacaftor in an adult with severe lung disease due to cystic fibrosis (DeltaF508\/G551D)","volume":"12","author":"Polenakovik","year":"2013","journal-title":"J\u00a0Cyst Fibros"},{"issue":"1","key":"10.1016\/j.ccm.2022.07.002_bib108","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcf.2015.01.008","article-title":"Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: safety and efficacy in an expanded access program in the United States","volume":"15","author":"Taylor-Cousar","year":"2016","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.ccm.2022.07.002_bib109","doi-asserted-by":"crossref","first-page":"106073","DOI":"10.1016\/j.rmed.2020.106073","article-title":"Ivacaftor improves lung disease in patients with advanced CF carrying CFTR mutations that confer residual function","volume":"171","author":"Salvatore","year":"2020","journal-title":"Respir Med"},{"issue":"17","key":"10.1016\/j.ccm.2022.07.002_bib110","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa1807120","article-title":"VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles","volume":"379","author":"Keating","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.ccm.2022.07.002_bib111","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"10212","key":"10.1016\/j.ccm.2022.07.002_bib112","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ccm.2022.07.002_bib113","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1164\/rccm.202011-4153OC","article-title":"Rapid improvement after Starting elexacaftor-tezacaftor-ivacaftor in patients with cystic fibrosis and advanced pulmonary disease","volume":"204","author":"Burgel","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2022.07.002_bib114","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jcf.2019.05.015","article-title":"Disease progression in patients with cystic fibrosis treated with ivacaftor: data from national US and UK registries","volume":"19","author":"Volkova","year":"2020","journal-title":"J\u00a0Cyst Fibros"},{"issue":"2","key":"10.1016\/j.ccm.2022.07.002_bib115","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.jcf.2017.09.006","article-title":"Ivacaftor withdrawal syndrome in cystic fibrosis patients with the G551D mutation","volume":"17","author":"Trimble","year":"2018","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.ccm.2022.07.002_bib116","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jcf.2022.04.009","article-title":"Use of elexacaftor\/tezacaftor\/ivacaftor among cystic fibrosis lung transplant recipients.","volume":"21","author":"Ramos","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"7","key":"10.1016\/j.ccm.2022.07.002_bib117","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.healun.2021.04.011","article-title":"Cystic fibrosis foundation consensus statements for the care of cystic fibrosis lung transplant recipients.","volume":"40","author":"Shah","year":"2021","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.ccm.2022.07.002_bib118","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jcf.2022.01.012","article-title":"Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis.","volume":"21","author":"Martin","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.ccm.2022.07.002_bib119","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1111\/ajt.16360","article-title":"Type-1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction","volume":"21","author":"Iasella","year":"2021","journal-title":"Am J Transplant"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027252312200079X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027252312200079X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:18:44Z","timestamp":1759454324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027252312200079X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":119,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S027252312200079X"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2022.07.002","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on Lung Transplantation for Cystic Fibrosis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2022.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}